CFTR and hepatocellular carcinoma: Seventy-two CF glycosylation sites were also detected by HCC label-free data (Supplementary Data 4), and the differential expression of 52 CF glycosites were further validated in the label-free data (Supplementary Data 10), suggesting the reliability of our reported tumor-associated CF glycosylation events.